Discover how understanding your viral load and CD4 count puts you in control of HIV treatment and transforms confusing ...

More than 15% of individuals living with HIV and cancer have not received recommended first-line cancer therapy, according to results of a retrospective analysis.Among patients with HIV and cancer, ...

There is still no cure or effective vaccine for HIV-1, which remains a public health threat. But scientists have opened up new possibilities in HIV treatment and vaccine development. Colorized ...

Treatment is lifelong, and we ensure that every facility has trained case managers who guide and monitor our patients.” To reach remote and underserved areas, the DOH also runs the “PuroKalusugan” ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...

This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.

The health department's goal is to find 1.1-million people who know they have HIV , but either never started treatment, or fell out of treatment, before the end of the year.

The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development ...

The twice-yearly shot lenacapavir, sold under the name Yeztugo, reportedly nearly eliminated new HIV infections in studies of ...

The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But ...

The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...